Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Maze Therapeutics, Inc. (MAZE) vs. Competitors

128 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MAZEMaze Therapeutics, Inc.$31.20$1.71B-10.87-6.11%Strong BuyUnlock the MAZE analyst price target with TipRanks PremiumMAZEUnlock the MAZE top-analyst price target with TipRanks Premium
NTLAIntellia Therapeutics$9.77$1.37B-2.9215.35%HoldUnlock the NTLA analyst price target with TipRanks PremiumMAZE vs NTLAUnlock the NTLA top-analyst price target with TipRanks Premium
DMRADamora Therapeutics$22.98$1.40B-0.1910.11%Strong BuyUnlock the DMRA analyst price target with TipRanks PremiumMAZE vs DMRAUnlock the DMRA top-analyst price target with TipRanks Premium
RXRXRecursion Pharmaceuticals$2.83$1.76B-3.14-32.09%Moderate BuyUnlock the RXRX analyst price target with TipRanks PremiumMAZE vs RXRXUnlock the RXRX top-analyst price target with TipRanks Premium
DNAGinkgo Bioworks Holdings$8.44$547.12M-2.007.79%Moderate SellUnlock the DNA analyst price target with TipRanks PremiumMAZE vs DNAUnlock the DNA top-analyst price target with TipRanks Premium
GENBGenerate Biomedicines, Inc.$10.38$1.34B-4.38-17.94%Strong BuyUnlock the GENB analyst price target with TipRanks PremiumMAZE vs GENBUnlock the GENB top-analyst price target with TipRanks Premium

Performance Comparison

-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MAZEMaze Therapeutics, Inc.31.20-4.37-12.29%
NTLAIntellia Therapeutics9.771.7321.52%
DMRADamora Therapeutics22.985.6332.45%
RXRXRecursion Pharmaceuticals2.83-1.02-26.62%
DNAGinkgo Bioworks Holdings8.440.627.93%
GENBGenerate Biomedicines, Inc.10.38-2.27-17.94%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts